Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 43 matching records.
43 results — page 1 of 2
- Level CProspective StudyPubMed
Case Report: Dramatic metabolic improvement with tirzepatide in a patient with acquired partial lipodystrophy following hematopoietic stem cell transplantation.
Prospective Study on Type 2 Diabetes, published in Front Endocrinol (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
Front Endocrinol (Lausanne) - Level DNarrative ReviewPubMed
Hematopoietic stem cell transplantation-associated partial lipodystrophy.
Narrative Review with a reported sample of 17 on Type 2 Diabetes, published in Clin Pediatr Endocrinol (2026) — summary generated from the PubMed abstract.
- 2026
- n = 17
Clin Pediatr Endocrinol - Level DAnimal StudyEurope PMC
Integrin β2 Plays a Significant Role in Therapeutic Angiogenesis Through Hematopoietic Stem Cell Transplantation
Animal Study on Stroke Research, published in Life (Basel) (2025) — summary generated from the PubMed abstract.
- 2025
Life (Basel)1 citations - Level AMeta-analysisEurope PMC
Mesenchymal stem cells added to second-line therapy improve response and failure-free survival in steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A meta-analys
Meta-analysis with a reported sample of 650 on Immune Modulation, published in Front Oncol (2025) — summary generated from the PubMed abstract.
- 2025
- n = 650
Front Oncol - Level ASystematic ReviewEurope PMC
Comparative Efficacy of Autologous Hematopoietic and Mesenchymal Stem Cell Transplantation in Patients with Systemic Sclerosis: A Systematic Review
Systematic Review with a reported sample of 504 on Autoimmune Research, published in J Clin Med (2025) — summary generated from the PubMed abstract.
- 2025
- n = 504
J Clin Med - Level CRetrospective StudyPubMed
Low subcutaneous adipose tissue and myosteatosis are prognostic factors after allogeneic hematopoietic stem cell transplantation.
Retrospective Study, published in Clin Nutr ESPEN (2024) — summary generated from the PubMed abstract.
- 2024
Clin Nutr ESPEN - Level CProspective StudyPubMed
Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Prospective Study with a reported sample of 46 on Immune Modulation, published in Ann Hematol (2023) — summary generated from the PubMed abstract.
- 2023
- n = 46
Ann Hematol - Level CRetrospective StudyPubMed
The association of body composition and outcomes following autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma.
Retrospective Study, published in Bone Marrow Transplant (2023) — summary generated from the PubMed abstract.
- 2023
Bone Marrow Transplant - Level CProspective StudyPubMed
Evaluation of safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells in pediatric bronchiolitis obliterans syndrome (BoS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Prospective Study on Scar, Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
- 2023
Stem Cell Res Ther9 citations - Level CCase Report / SeriesPubMed
Influence of diet and body weight in treatment-resistant acquired partial lipodystrophy after hematopoietic stem cell transplantation and its potential for metabolic improvement.
Case Report / Series on Type 2 Diabetes, published in Diabetol Int (2023) — summary generated from the PubMed abstract.
- 2023
Diabetol Int - Level CRetrospective StudyPubMed
Intramuscular Adipose Tissue Content Predicts Patient Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation.
Retrospective Study, published in Transplant Cell Ther (2022) — summary generated from the PubMed abstract.
- 2022
Transplant Cell Ther - Level DAnimal StudyPubMed
How mesenchymal stem cell cotransplantation with hematopoietic stem cells can improve engraftment in animal models.
Animal Study on Systemic / IV, published in World J Stem Cells (2022) — summary generated from the PubMed abstract.
- 2022
World J Stem Cells5 citations - Level CRetrospective StudyPubMed
Prognostic Impact of Quantifying Sarcopenia and Adipopenia by Chest CT in Severe Aplastic Anemia Patients Treated With Allogeneic Hematopoietic Stem Cell Transplantation.
Retrospective Study, published in Acad Radiol (2022) — summary generated from the PubMed abstract.
- 2022
Acad Radiol - Level CProspective StudyPubMed
Mesenchymal stromal cells as treatment for acute respiratory distress syndrome. Case Reports following hematopoietic cell transplantation and a review.
Prospective Study on Chronic Inflammation, published in Front Immunol (2022) — summary generated from the PubMed abstract.
- 2022
Front Immunol - Level DLaboratory StudyEurope PMC
Creation of human hematopoietic chimeric cell (HHCC) line as a novel strategy for tolerance induction in transplantation
Laboratory Study on Immune Modulation, published in Stem Cell Investig (2022) — summary generated from the PubMed abstract.
- 2022
Stem Cell Investig5 citations - Level CProspective StudyPubMed
Impact of Obesity and Visceral Fat on Mortality in Hematopoietic Stem Cell Transplantation.
Prospective Study with a reported sample of 50, published in JPEN J Parenter Enteral Nutr (2021) — summary generated from the PubMed abstract.
- 2021
- n = 50
JPEN J Parenter Enteral Nutr - Level CRetrospective StudyPubMed
Prevalence of low skeletal muscle quantity and quality and their associated factors in patients before allogeneic hematopoietic stem cell transplantation.
Retrospective Study, published in Intern Emerg Med (2021) — summary generated from the PubMed abstract.
- 2021
Intern Emerg Med - Level CProspective StudyPubMed
Gastrointestinal peptides in children before and after hematopoietic stem cell transplantation.
Prospective Study with a reported sample of 27, published in BMC Cancer (2020) — summary generated from the PubMed abstract.
- 2020
- n = 27
BMC Cancer - Level BClinical TrialPubMed
Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease.
Clinical Trial on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in Front Immunol (2020) — summary generated from the PubMed abstract.
- 2020
Front Immunol - Level CProspective StudyPubMed
Metreleptin worked in a diabetic woman with a history of hematopoietic stem cell transplantation (HSCT) during infancy: further support for the concept of 'HSCT-associated lipodystrophy'.
Prospective Study on Type 2 Diabetes, published in Endocr J (2020) — summary generated from the PubMed abstract.
- 2020
Endocr J - Level CProspective StudyPubMed
Acquired partial lipodystrophy with metabolic disease in children following hematopoietic stem cell transplantation: a report of two cases and a review of the literature.
Prospective Study on Immune Modulation, published in J Pediatr Endocrinol Metab (2019) — summary generated from the PubMed abstract.
- 2019
J Pediatr Endocrinol Metab - Level AMeta-analysisEurope PMC
The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease
Meta-analysis on Immune Modulation, published in Stem Cell Res Ther (2019) — summary generated from the PubMed abstract.
- 2019
Stem Cell Res Ther128 citations - Level DAnimal StudyEurope PMC
Co-transplantation of Human Fetal Mesenchymal and Hematopoietic Stem Cells in Type 1 Diabetic Mice Model
Animal Study on Type 1 Diabetes, published in Front Endocrinol (Lausanne) (2019) — summary generated from the PubMed abstract.
- 2019
Front Endocrinol (Lausanne)15 citations - Level CCase Report / SeriesPubMed
Sarcopenic obesity derived from PET/CT predicts mortality in lymphoma patients undergoing hematopoietic stem cell transplantation.
Case Report / Series with a reported sample of 93 on Scar, published in Curr Res Transl Med (2018) — summary generated from the PubMed abstract.
- 2018
- n = 93
Curr Res Transl Med
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406